Enovis Debt to Equity Ratio 2010-2023 | ENOV
Enovis Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2023-12-31 | $1.09B | $3.42B | 0.32 |
2023-09-30 | $0.96B | $3.44B | 0.28 |
2023-06-30 | $0.99B | $3.45B | 0.29 |
2023-03-31 | $0.85B | $3.45B | 0.25 |
2022-12-31 | $0.82B | $3.45B | 0.24 |
2022-09-30 | $1.04B | $3.41B | 0.30 |
2022-06-30 | $1.01B | $3.49B | 0.29 |
2022-03-31 | $3.84B | $4.64B | 0.83 |
2021-12-31 | $3.85B | $4.66B | 0.83 |
2021-09-30 | $3.34B | $4.63B | 0.72 |
2021-06-30 | $3.21B | $4.35B | 0.74 |
2021-03-31 | $3.78B | $4.29B | 0.88 |
2020-12-31 | $3.76B | $3.59B | 1.05 |
2020-09-30 | $3.70B | $3.46B | 1.07 |
2020-06-30 | $3.73B | $3.40B | 1.10 |
2020-03-31 | $4.12B | $3.34B | 1.23 |
2019-12-31 | $3.90B | $3.49B | 1.12 |
2019-09-30 | $6.46B | $3.13B | 2.06 |
2019-06-30 | $6.64B | $3.26B | 2.04 |
2019-03-31 | $6.76B | $3.74B | 1.81 |
2018-12-31 | $3.14B | $3.48B | 0.90 |
2018-09-30 | $2.97B | $3.48B | 0.85 |
2018-06-30 | $2.93B | $3.54B | 0.83 |
2018-03-31 | $3.04B | $3.84B | 0.79 |
2017-12-31 | $2.98B | $3.73B | 0.80 |
2017-09-30 | $3.33B | $3.51B | 0.95 |
2017-06-30 | $3.36B | $3.37B | 1.00 |
2017-03-31 | $3.22B | $3.21B | 1.00 |
2016-12-31 | $3.25B | $3.09B | 1.05 |
2016-09-30 | $3.37B | $3.17B | 1.07 |
2016-06-30 | $3.42B | $3.16B | 1.08 |
2016-03-31 | $3.49B | $3.24B | 1.08 |
2015-12-31 | $3.48B | $3.26B | 1.07 |
2015-09-30 | $3.74B | $3.30B | 1.13 |
2015-06-30 | $3.58B | $3.43B | 1.05 |
2015-03-31 | $3.70B | $3.25B | 1.14 |
2014-12-31 | $3.86B | $3.35B | 1.15 |
2014-09-30 | $3.99B | $3.54B | 1.13 |
2014-06-30 | $4.28B | $3.65B | 1.17 |
2014-03-31 | $3.38B | $3.40B | 0.99 |
2013-12-31 | $3.86B | $2.74B | 1.41 |
2013-09-30 | $3.76B | $2.57B | 1.47 |
2013-06-30 | $3.69B | $2.40B | 1.54 |
2013-03-31 | $3.78B | $2.06B | 1.83 |
2012-12-31 | $3.99B | $2.16B | 1.85 |
2012-09-30 | $3.88B | $2.18B | 1.78 |
2012-06-30 | $3.90B | $2.10B | 1.85 |
2012-03-31 | $3.91B | $2.22B | 1.76 |
2011-12-31 | $0.90B | $0.19B | 4.75 |
2011-09-30 | $0.79B | $0.25B | 3.23 |
2011-06-30 | $0.81B | $0.25B | 3.18 |
2011-03-31 | $0.83B | $0.24B | 3.47 |
2010-12-31 | $0.81B | $0.22B | 3.72 |
2010-09-30 | $0.78B | $0.23B | 3.44 |
2010-06-30 | $0.78B | $0.19B | 4.23 |
2010-03-31 | $0.80B | $0.19B | 4.12 |
2009-12-31 | $0.79B | $0.22B | 3.64 |
2009-09-30 | $0.83B | $0.20B | 4.21 |
2009-06-30 | $0.72B | $0.18B | 3.91 |
2009-03-31 | $0.72B | $0.17B | 4.27 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $3.030B | $1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
Axonics (AXNX) | United States | $3.401B | 0.00 |
10x Genomics (TXG) | United States | $3.288B | 0.00 |
Azenta (AZTA) | United States | $2.910B | 237.18 |
Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
Privia Health (PRVA) | United States | $2.167B | 96.11 |
Schrodinger (SDGR) | United States | $1.733B | 0.00 |
Omnicell (OMCL) | United States | $1.279B | 31.30 |
Phreesia (PHR) | United States | $1.162B | 0.00 |
Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
Standard BioTools (LAB) | United States | $0.708B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
Talkspace (TALK) | United States | $0.527B | 0.00 |
Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
Pulmonx (LUNG) | United States | $0.281B | 0.00 |
Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
American Well (AMWL) | United States | $0.153B | 0.00 |
MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
Augmedix (AUGX) | United States | $0.139B | 0.00 |
Outset Medical (OM) | United States | $0.124B | 0.00 |
TruBridge (TBRG) | United States | $0.118B | 5.03 |
111 (YI) | China | $0.086B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
Movano (MOVE) | United States | $0.026B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
Akili (AKLI) | United States | $0.019B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
ETAO (ETAO) | United States | $0.015B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |